185,804 Shares in HCA Healthcare, Inc. $HCA Bought by VIRGINIA RETIREMENT SYSTEMS ET Al

VIRGINIA RETIREMENT SYSTEMS ET Al purchased a new stake in shares of HCA Healthcare, Inc. (NYSE:HCA) during the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 185,804 shares of the company’s stock, valued at approximately $72,443,000. VIRGINIA RETIREMENT SYSTEMS ET Al owned approximately 0.09% of HCA Healthcare at the end of the most recent quarter.

Several other hedge funds have also added to or reduced their stakes in HCA. California State Teachers Retirement System raised its stake in shares of HCA Healthcare by 38,348.7% during the second quarter. California State Teachers Retirement System now owns 89,141,330 shares of the company’s stock valued at $34,755,313,000 after acquiring an additional 88,909,485 shares during the last quarter. BlackRock Inc. acquired a new stake in HCA Healthcare in the second quarter valued at $5,069,974,000. State Street Corp grew its position in shares of HCA Healthcare by 1.0% in the 4th quarter. State Street Corp now owns 7,566,643 shares of the company’s stock valued at $3,532,563,000 after buying an additional 76,039 shares during the last quarter. Capital World Investors raised its position in shares of HCA Healthcare by 0.8% during the fourth quarter. Capital World Investors now owns 4,999,422 shares of the company’s stock worth $2,334,040,000 after acquiring an additional 40,086 shares during the last quarter. Finally, Wellington Management Group LLP boosted its holdings in HCA Healthcare by 20.5% in the second quarter. Wellington Management Group LLP now owns 4,707,473 shares of the company’s stock valued at $1,835,397,000 after acquiring an additional 799,761 shares during the last quarter. 62.73% of the stock is currently owned by institutional investors and hedge funds.

HCA Healthcare Stock Performance

HCA stock opened at $404.95 on Monday. The company has a market cap of $87.67 billion, a P/E ratio of 13.56, a price-to-earnings-growth ratio of 1.33 and a beta of 1.10. HCA Healthcare, Inc. has a fifty-two week low of $353.99 and a fifty-two week high of $556.52. The stock’s 50 day simple moving average is $403.35 and its 200 day simple moving average is $436.82.

HCA Healthcare (NYSE:HCA) last issued its earnings results on Friday, July 24th. The company reported $7.59 earnings per share for the quarter, topping analysts’ consensus estimates of $7.56 by $0.03. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.The company had revenue of $20.23 billion for the quarter, compared to analyst estimates of $19.76 billion. During the same period in the prior year, the firm earned $6.84 earnings per share. HCA Healthcare’s revenue for the quarter was up 8.7% on a year-over-year basis. Equities analysts predict that HCA Healthcare, Inc. will post 29.42 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 30th. Investors of record on Wednesday, September 16th will be given a $0.78 dividend. The ex-dividend date of this dividend is Wednesday, September 16th. This represents a $3.12 annualized dividend and a yield of 0.8%. HCA Healthcare’s dividend payout ratio (DPR) is presently 10.45%.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on HCA. KeyCorp reduced their price objective on shares of HCA Healthcare from $475.00 to $435.00 and set an “overweight” rating on the stock in a research note on Monday, July 27th. JPMorgan Chase & Co. cut their price target on shares of HCA Healthcare from $490.00 to $425.00 and set a “neutral” rating on the stock in a research report on Thursday, August 20th. Sanford C. Bernstein reissued a “market perform” rating on shares of HCA Healthcare in a research note on Wednesday, July 15th. Royal Bank Of Canada reaffirmed an “outperform” rating and set a $435.00 target price on shares of HCA Healthcare in a research note on Monday, July 27th. Finally, Truist Financial cut their price target on HCA Healthcare from $535.00 to $495.00 and set a “buy” rating on the stock in a report on Monday, July 27th. Fourteen equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $462.64.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.